A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

Clinical trial NCT06466785 · RECRUITING

Trial details

NCT number: NCT06466785
Sponsor: Genexine, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Anemia of Chronic Kidney Disease

Start date: 2024-01-25
Primary completion: 2027-06-01
Enrollment: 429

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.